Ritsinger et al. studied the value of adipokines (plasma leptin and total adiponectin) as predictive biomarkers in 181 patients with AMI and no known diagnosis of diabetes, over a median follow-up of 11.6 years. Here, ADIPOQ is linked to diabetes mellitus.